期刊文献+

急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入术前应用负荷剂量阿托伐他汀的疗效观察 被引量:1

Observation on Efficacy of Loading Dose Atorvastatin in Treatment of ST-segment Elevation Myocardial Infarction Before Emergency Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:探讨急诊经皮冠状动脉介入(percutaneous coronary intervention,PCI)术前应用负荷剂量阿托伐他汀对急性ST段抬高型心肌梗死(ST-segment elevation myocardial infarction,STEMI)患者的临床疗效。方法:选取丹江口市第一医院108例拟行急诊PCI术的STEMI患者,根据手术顺序将其编号,奇数者纳入对照组(54例),偶数者纳入观察组(54例)。对照组患者术后常规应用阿托伐他汀,观察组患者术前应用负荷剂量阿托伐他汀+术后常规应用阿托伐他汀。比较2组患者手术前后超敏C反应蛋白(hs-CRP)、B型钠酸肽(BNP)、基质金属蛋白酶9(MMP-9)、左心室射血分数(LVEF)等指标水平及主要不良心血管事件发生率。结果:术后1个月,观察组患者hs-CRP、BNP、MMP-9水平均显著低于对照组,差异均有统计学意义(P<0.05);术后3个月,观察组患者LVEF水平显著优于对照组,差异有统计学意义(P<0.05);观察组患者主要不良心血管事件发生率为3.70%(2/54),显著低于对照组的14.81%(8/54),差异有统计学意义(P<0.05)。结论:急诊PCI术前应用负荷剂量阿托伐他汀,可有效缓解STEMI患者炎症反应程度,改善患者心肌功能,降低主要不良心血管事件发生率。 OBJECTIVE: To probe into the clinical efficacy of loading dose atorvastatin in treatment of ST-segment elevation myocardial infarction( STEMI) before emergency percutaneous coronary intervention( PCI). METHODS: 108 STEMI patients accepting emergency PCI in the First Hospital of Danjiangkou were selected,according to the operation sequence,odd number was set as the control group( 54 cases),even number was set as the observation group( 54 cases).The control group were treated with atorvastatin as conventional treatment after operation,while the observation group were given loading dose atorvastatin before operation and atorvastatin as conventional treatment after operation. The hs-CRP,BNP,MMP-9 and LVEF and incidence of major adverse cardiovascular events of two groups were observed. RESULTS:After operation of 1 month,the level of hs-CRP,BNP,MMP-9 in observation group were significantly lower than that of control group,with statistically significant difference( P〈0. 05). After treatment of 3 months,the level of LVEF in observation group was significantly higher than that of control group,with statistically significant difference( P〈0. 05). The incidence of adverse cardiovascular events of observation group was 3. 70%( 2 /54),significantly lower than that of control group[14. 81%( 8 /54) ],with statistically significant difference( P〈0. 05). CONCLUSIONS: Application of loading doses atorvastatin before emergency PCI can effectively alleviate the inflammation degree,improve cardiac function and reduce the incidence of adverse cardiovascular events in patients with STEMI.
出处 《中国医院用药评价与分析》 2017年第1期32-33,36,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 2016十堰市科学技术研究项目(No.16Y93)
关键词 急性ST段抬高型心肌梗死 经皮冠状动脉介入 阿托伐他汀 ST-segment elevation myocardial infarction Percutaneous coronary intervention Atorvastatin
  • 相关文献

参考文献15

二级参考文献191

  • 1于建刚,钱建东,徐红,袁雪芬,徐丽芳,朱建琴.阿托伐他汀钙对脑梗死患者颈动脉斑块影响的临床研究[J].华西医学,2008,23(6):1305-1306. 被引量:14
  • 2孙华保,宁丹霞,李泽林,陈杰,李庆军,梁国钦,王广兴,刘年安.不同剂量阿托伐他汀对急性冠状动脉综合征患者sCD40L及其预后影响[J].中国医师杂志,2005,7(7):900-902. 被引量:4
  • 3邸晓辉,杨永革,梅巍,刘静,许雪廷.阿托伐他汀钙胶囊的人体生物等效性研究[J].解放军药学学报,2005,21(4):262-265. 被引量:8
  • 4MARITIM AC, SANDERS RA,WAT KINS JB. Diabetes, oxidative stress and antioxidants [ J ]. Biochem Mol Toxicol, 2003,17 (1) :24 -38.
  • 5GRAWEL S,WARDAS M, WOROKE N,et al. Malondialdehyde (MDA) as a lipid peroxidation marker[ J]. Wiad Lek,2004,57 (9 - 10) :453 -455.
  • 6SONG YB,ON YK, KIM JH,et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off2pump coronary artery bypass grafting surgery [ J ]. Am Heart J, 2008, 156(2) :9 -16.
  • 7TSAI CT,LAI LP,HWANG JJ,et al. Atorvastatin prevents atrial fibrillation in patients with bradyar rhythm ias and implantation of an atrial-based or dual-chain-bet pacemaker: a prospective randomized trial [ J ]. Am Heart J, 2008,156 ( 1 ) : 65 - 70.
  • 8GILLIS AM,MORCK M,EXNER DV,et al. Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker imp lantation [ J ]. Eur Heart J, 2008,29 ( 15 ) : 1873 - 1880.
  • 9LEE SH,CHUNG N,KWAN J,et al. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin : an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia [ J ]. Clin Ther, 2007,29 ( 11 ) :2365 -2373.
  • 10YOSHITOMI Y, ISHII T, KANEKI M,et al. Efficacy of a low dose of pitavastatin compared with atorvaststin in primary hyperlipidemia : result of a 12-week, open label study [ J ]. J Atheroscler Thromb ,2006,13 ( 2 ) : 108 - 113.

共引文献381

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部